pCare and Moffitt Cancer Center have partnered for the ongoing integration and support of pCare’s end-to-end interactive patient care system into the recently opened inpatient surgical facility at Moffitt Cancer Center McKinley Hospital (The Cancer Letter, July 28, 2023).
Researchers leading the SWOG S1712 clinical trial have found that adding ruxolitinib (Jakafi) to standard tyrosine kinase inhibitor treatment for patients with chronic-phase chronic myeloid leukemia significantly increased the percentage of patients who had a molecular response deep enough to warrant discontinuing treatment. Results were presented at the European School of Haematology’s 26th Annual John...
